Read more about how MaxQ demonstrates MaxTrace Value to Big Pharma

One of the world’s largest pharmaceutical companies is extending deployment of the MaxTrace™ predictive cloud engine following the successful completion of an 8-week proof-of-value initiative in October 2021. This was phase 1 of a multi-phase collaboration with MaxQ, the specialist cold-chain packaging, predictive intelligence and automation company. The two organizations are now undertaking subsequent phases covering operational validation, scaling and expansion, and automation.